/

Empresas

Al

No verificado

Allay Therapeutics

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

05/06/2025

Mercado laboral

Industria

Biotecnología

Medicina - Varios

Salud

Farmacéutica

Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line to Advance ATX101 and its Ultra-Sustained Pain Platform for Post-Surgical Pain Management

Fuente

Allay Therapeutics

Editor

1.00

0

18/02/2025

Industria

Biotecnología

Medicina - Varios

Salud

Farmacéutica

Allay Therapeutics Announces First Patients Dosed in Pivotal Phase 2b Registration Trial of ATX101 for Post-Surgical Pain Management After Knee Replacement Surgery

Fuente

Allay Therapeutics

Editor

1.00

0

04/12/2024

Industria

Ciencia

Biotecnología

Sanidad

Medicina - Varios

Salud

Higiene alimentaria

Allay Therapeutics Receives FDA Breakthrough Therapy Designation (BTD) for ATX101 for the Treatment of Post-surgical Pain Following Total Knee Replacement Surgery

Fuente

Allay Therapeutics

Editor

1.00

0

24/10/2024

Mercado laboral

Industria

Ciencia

Medicina - Varios

Biotecnología

Sanidad

Salud

Farmacéutica

Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Transform Post-Surgical Pain Management

Fuente

Allay Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0